CALIFORNIA

More news

Cepheid's bacteria infection test gets FDA OK

The U.S. Food and Drug Administration (FDA) has approved molecular diagnostics company Cepheid (NASDAQ: CPHD)'s test designed to detect the toxin associated with a common bacterial infection that can cause diarrhea and other serious intestinal conditions and death in severe cases.
IBTimes Logo

How Apple earned the Midas touch

Speculation abounds as to when Apple's new iPhone will hit shelves, but the company has created such a successful dynamic surrounding its products that timing may be irrelevant.
Switzerland

Apple iOS is the 'What's Next'

Speculation abounds as to when Apple's new iPhone will hit shelves, but the company has created such a successful dynamic surrounding its products that timing may be irrelevant.
IBTimes Logo

Steve Wozniak says would consider return to Apple

Steve Wozniak would consider returning to an active role at Apple, the company he co-founded, and believes the consumer electronics giant could afford to be more open than it is, he told Reuters.
IBTimes Logo

Questcor Pharma Shares Hit New Life-Time High Again

Shares of Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) touched a new life-time high of $18.73 on Thursday. The company issued preliminary metrics for the first quarter. The positive results were reflected in the trading of Questcor stock that reached a new life-time high for third time during this week.
The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland

FDA OK's device to treat brain aneurysms

The U.S. Food and Drug Administration (FDA) cleared a new device, manufactured by California-based ev3, to treat brain aneurysms without performing open surgery.
Broadcom CEO Scott McGregor stands in front of the company's logo in Taipei

Broadcom Upgraded at Oppenheimer

Oppenheimer has upgraded shares of Broadcom to outperform from perform citing strong growth profile, management's stated efforts to pursue profitable growth, a more disciplined operating expense and compensation strategy.
IBTimes Logo

Questcor Pharma Shares Hit Life-Time High

Shares of Questcor Pharmaceuticals, Inc. (QCOR) touched a new life-time high of $18.50 on Tuesday. The company issued preliminary metrics for the first quarter, whereby it projects a 115 percent first quarter surge in sales of its main drug H.P. Acthar Gel that is used to treat certain disorders with an inflammatory component.
Charlie seeking trademark on 'Sheen-isms'

Charlie seeking trademark on 'Sheen-isms'

Scandalous star, Charlie Sheen, is reportedly busy in a legal application seeking to trademark 22 of his famous catchphrases, which have also come to be dubbed Sheen-isms.
Google

Gmail Motion: Researchers make real what Google dubbed as joke

Google’s Gmail Motion prank on April Fool had left many in the tech world wondering why Google, or just anybody else, wouldn’t make it real. Now it has emerged that researchers at the University of Southern California have made it real by using Microsoft’s Xbox 360 Kinect peripheral. They hacked into the Microsoft Kinect's motion-sensing technology and also used what they have called the Flexible Action and Articulated Skeleton Toolkit (FAAST) to create what Gmail brushed off as a prank.
IBTimes Logo

Calix Shares to Sell Off Modestly on Tuesday: Analyst

Jefferies & Co. expects that shares of Calix, Inc. (NYSE: CALX) will sell off modestly on Tuesday as investors contemplate another round of very conservative guidance from the company. The brokerage reiterated its buy rating on shares of Calix, while increasing its price target to $24.50 from $16.

Pages

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.